Antifungal Prophylaxis and Preemptive Therapy to Prevent COVID-19-Associated Pulmonary Aspergillosis in Patients Requiring Advanced Respiratory Support: A Real-World Cohort Study in China [0.03%]
在中国需要高级呼吸支持的患者中预防COVID-19相关性肺曲霉病的抗真菌预防和预警治疗：中国真实世界队列研究
Siqi Pan,Huaiya Xie,Yaqi Wang et al.
Siqi Pan et al.
Objectives: COVID-19-associated pulmonary aspergillosis (CAPA) is a frequent and life-threatening complication in critically ill patients. However, the role of antifungal prophylaxis and preemptive therapy remains unclear...
Multidisciplinary Care Should Be the Standard in Referral Centers for Non tuberculous Mycobacterial Disease [0.03%]
非结核分枝杆菌病转诊中心应提供多学科治疗标准
Giovanni Fumagalli,Niccolò Riccardi
Giovanni Fumagalli
Multidisciplinary care should be the standard in referral centers for non tuberculous mycobacterial disease [0.03%]
非结核分枝杆菌病转诊中心应提供多学科治疗标准
Giovanni Fumagalli,Niccolò Riccardi
Giovanni Fumagalli
Emelie Bäcklin,Eva Breznik,Örjan Smedby et al.
Emelie Bäcklin et al.
Background: Expiratory CT and lobar analysis may provide complementary information to inspiratory CT and spirometry for identifying chronic airflow limitation (CAL), but their value in population-based cohorts remains ins...
Comprehensive assessment of complete blood count as a prognostic biomarker in interstitial lung diseases [0.03%]
全面评估完全血液计数作为间质性肺疾病的预后生物标志物的影响
Nimrod Urtreger,Kavitha Selvan,Ophir Freund et al.
Nimrod Urtreger et al.
Background: While prognostic changes in complete blood count (CBC) parameters, such as elevated monocytes and neutrophils, have been studied in idiopathic pulmonary fibrosis (IPF), they are less well characterized in othe...
Min Qi,Xu-Wen Fu,Yuan-Ying Li et al.
Min Qi et al.
Objective: Pulmonary mucormycosis (PM) presents with atypical clinical manifestations, making diagnosis challenging and leading to a high mortality rate. Therefore, this study aims to systematically compare the clinical s...
COPD case finding and identification of at-risk individuals: opportunities for early personalized intervention and disease interception [0.03%]
慢性阻塞性肺疾病病例发现及高危个体识别：早期个性化干预和截断疾病的机会
Alberto Papi,MeiLan K Han,Paola Rogliani et al.
Alberto Papi et al.
A substantial proportion of chronic obstructive pulmonary disease (COPD) cases remain undiagnosed, delaying appropriate care and allowing disease progression. Targeted case finding, particularly in symptomatic individuals and those at risk,...
Early and continued asthma control up to week 24 in patients with severe, uncontrolled asthma treated with tezepelumab: Initial results of the real-world ASCENT study [0.03%]
在ASCENT研究中，Tezepelumab治疗重度难治性哮喘患者至第24周早期且持续的控制效果：初步结果
Katrin Milger,Del Dorscheid,Christian Gessner et al.
Katrin Milger et al.
Introduction: Tezepelumab has demonstrated efficacy in patients with severe, uncontrolled asthma in randomized controlled trials (RCTs). Real-world studies assessing patient-reported outcomes are required to complement RC...
Matteo Martini,Lorenzo Cecchi,Antonino Musarra et al.
Matteo Martini et al.
Background: Mild and moderate asthma are the most common forms of asthma, but they often remain poorly controlled due to inappropriate treatment strategies and low adherence. Formal consensus on best practices for managin...
Correlation between pulmonary outcomes and nutritional status following treatment with elexacaftor/tezacaftor/ivacaftor in people with Cystic fibrosis [0.03%]
elexacaftor/tezacaftor/ivacaftor治疗囊性纤维化患者的肺部预后与营养状态之间的相关性研究
Malena Cohen-Cymberknoh,Yuval Aqua,Giselle Diab et al.
Malena Cohen-Cymberknoh et al.
Background: Elexacaftor/tezacaftor/ivacaftor (ETI) improves lung function and nutritional status in people with cystic fibrosis (pwCF); it is unclear whether these responses are correlated, and whether pancreatic status m...